SCHEMBL13487708

SCHEMBL13487708

CC1(C)c2ccccc2-c2cc(-c3c4ccccc4c(-c4cc(-c5ccccn5)cc(-c5ccccn5)c4)c4ccc(-c5ccc6ccccc6c5)cc34)ccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.37
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
PKM P14618 1/20 0.36
TSHR P16473 1/20 0.36
KLF5 Q13887 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ABL1 P00519 1/20 0.33
HTR2C P28335 1/20 0.33
DCTPP1 Q9H773 1/20 0.32
NPC1 O15118 1/20 0.32
SIRT2 Q8IXJ6 2/20 0.31
NPY5R Q15761 1/20 0.31
PIK3CD O00329 1/20 0.31
PIK3CA P42336 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13488086 0.95 PDK2 (0.40) PDK2KDM4EALDH1A1LMNATP53
SCHEMBL13487684 0.95 KDM4E (0.38) PDK2KDM4EALDH1A1LMNATP53
SCHEMBL13487774 0.92 PDK2 (0.42) PDK2KDM4EHTR2CNPC1NPY5R
SCHEMBL13487549 0.91 PDK2 (0.39) PDK2KDM4EALDH1A1LMNATP53
SCHEMBL13487636 0.90 HTR2C (0.39) PDK2KDM4EALDH1A1TP53MAPT
SCHEMBL13488050 0.90 PDK2 (0.40) PDK2KDM4EALDH1A1LMNATP53
SCHEMBL13487322 0.89 KDM4E (0.35) PDK2KDM4EALDH1A1LMNATP53
SCHEMBL13487662 0.89 SIRT2 (0.33) KDM4EALDH1A1LMNATP53MAPT
SCHEMBL13488166 0.88 PDK2 (0.44) PDK2KDM4EHTR2CNPC1NPY5R
SCHEMBL13487475 0.87 PDK2 (0.39) PDK2KDM4EALDH1A1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 PDK2 1456/4885KDM4E 3671/4885ALDH1A1 101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.